These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35478139)

  • 21. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Minichromosome Maintenance Proteins in Actinic Keratosis and Squamous Cell Carcinoma.
    Stojkovic-Filipovic J; Brasanac D; Bosic M; Boricic N; Lekic B
    Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):165-172. PubMed ID: 27299186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic genes related to the progression of actinic keratoses to cutaneous squamous cell carcinoma.
    Zhang L; Qin H; Wu Z; Chen W; Zhang G
    Int J Dermatol; 2018 Oct; 57(10):1208-1217. PubMed ID: 30105812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression landscape of cutaneous squamous cell carcinoma progression.
    Bencomo T; Lee CS
    Br J Dermatol; 2024 Oct; 191(5):760-774. PubMed ID: 38867481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
    Lambert SR; Mladkova N; Gulati A; Hamoudi R; Purdie K; Cerio R; Leigh I; Proby C; Harwood CA
    Br J Cancer; 2014 Jan; 110(2):520-9. PubMed ID: 24335922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
    Leiter U; Heppt MV; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; ElGammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1422-1433. PubMed ID: 37840404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
    Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
    JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
    Yoshifuku A; Fujii K; Kanekura T
    J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive diagnosis of early cutaneous squamous cell carcinoma.
    Azimi A; Jabbour S; Patrick E; Fernandez-Penas P
    Exp Dermatol; 2023 Nov; 32(11):1946-1959. PubMed ID: 37688398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
    Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
    Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
    Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.
    Bromfield JI; Zaugg J; Straw RC; Cathie J; Krueger A; Sinha D; Chandra J; Hugenholtz P; Frazer IH
    mSphere; 2024 Apr; 9(4):e0055523. PubMed ID: 38530017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of retinoic acid receptor-related receptor alpha (Rorα) promotes the progression of UV-induced cSCC.
    Zhang G; Yan G; Fu Z; Wu Y; Wu F; Zheng Z; Fang S; Gao Y; Bao X; Liu Y; Wang X; Zhu S
    Cell Death Dis; 2021 Mar; 12(3):247. PubMed ID: 33664254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma.
    de Oliveira Poswar F; de Carvalho Fraga CA; Gomes ES; Farias LC; Souza LW; Santos SH; Gomez RS; de-Paula AM; Guimarães AL
    Int J Surg Pathol; 2015 Feb; 23(1):20-5. PubMed ID: 24984957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of asprosin and meteorin-like peptide in progression of actinic keratosis to squamous cell carcinoma.
    Inan Yuksel E; Cicek D; Demir B; Kocaman N; Calik I; Kuloglu T
    Biotech Histochem; 2024 Feb; 99(2):61-68. PubMed ID: 38192243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
    Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
    JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.
    Murata M; Ito T; Tanaka Y; Yamamura K; Furue K; Furue M
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32106476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.